Amino acid hydration formulation and method of use

Patent metadata

Field	Value
Publication number	US-2024252580-A1
Application number	US-202218565042-A
Country	US
Kind code	A1
Filing date	May 27, 2022
Priority date	May 28, 2021
Publication date	Aug 1, 2024
Grant date	—

Abstract

The present disclosure presents compositions and methods for hydration or rehydration. A composition for oral consumption comprises an amino acid formulation. A method of hydrating or rehydrating a human, the method comprising administering an effective amount of an oral composition, wherein the oral composition comprises an amino acid formulation. The amino acid formulation may include an amino acid, a dipeptide, an oligopeptide, a carbohydrate-amino acid complex, or any combinations thereof.

First claim

What is claimed is:

1 . An oral composition for hydration or rehydration, the oral composition comprising an amino acid formulation.

2 . The oral composition of claim 1 , wherein the amino acid formulation comprises a compound selected from the group consisting of an amino acid, a dipeptide, a carbohydrate-amino acid complex, or any combination thereof.

3 . The oral composition of any one of claims 1-2 , wherein the amino acid is selected from the group consisting of leucine, isoleucine, valine, histidine, lysine, methionine, phenylalanine, threonine, tryptophan, alanine, arginine, asparagine, aspartic acid, cysteine, glutamic acid, glutamine, glycine, proline, serine, and tyrosine, or any combination thereof.

4 . The oral composition of any one of claims 1-3 , wherein the dipeptide is selected from the group consisting of glycine-containing dipeptide, lysine-containing dipeptide, arginine-containing dipeptide, alanine-containing dipeptide, glutamine-containing dipeptide, or any combination thereof.

5 . The oral composition of any one of claims 1-4 , wherein the carbohydrate-amino acid complex is selected from the group consisting of glutamine-glucose, alanine-glucose, or both.

6 . The oral composition of claim 1 , wherein the amino acid formulation consists essentially of glycine, or a glycine-containing dipeptide, or both.

7 . The oral composition of any one of claims 1-6 , wherein the oral composition is a ready-to-drink hydrating beverage.

8 . The oral composition of claim 7 , wherein the concentration of the amino acid formulation is from about 1 g/L to about 50 g/L, or from about 2 g/L to about 30 g/L, or from about 3 g/L to about 30 g/L, or from about 4 g/L to about 20 g/L, or from about 5 g/L to about 10 g/L, or from about 0.05 g/L to about 1 g/L, based on the total volume of the oral composition.

9 . The oral composition of any one of claims 1-6 , wherein the oral composition is in a dry or semi-dry form.

10 . The oral composition of claim 9 , wherein the oral composition is a gum, tablet, capsule, or dry powder.

11 . A method of hydrating or rehydrating a human, the method comprising administering an oral composition, the oral composition comprising an amino acid formulation.

12 . The method of claim 11 , wherein the amino acid formulation comprises a compound selected from the group consisting of an amino acid, a dipeptide, a carbohydrate-amino acid complex, or any combination thereof.

13 . The method of any one of claims 11-12 , wherein the amino acid is selected from the group consisting of leucine, isoleucine, valine, histidine, lysine, methionine, phenylalanine, threonine, tryptophan, alanine, arginine, asparagine, aspartic acid, cysteine, glutamic acid, glutamine, glycine, proline, serine, and tyrosine, or any combination thereof.

14 . The method of any one of claims 11-13 , wherein the dipeptide is selected from the group consisting of glycine-containing dipeptide, lysine-containing dipeptide, arginine-containing dipeptide, alanine-containing dipeptide, glutamine-containing dipeptide, or any combination thereof.

15 . The method of any one of claims 11-14 , wherein the carbohydrate-amino acid complex is selected from the group consisting of glutamine-glucose, alanine-glucose, or both.

16 . The method of any one of claims 11-15 , wherein the plasma volume of the human is increased by at least about 2.5%, or at least about 3%, or at least about 4% on or before 5 minutes after administration of the oral composition.

17 . The method of any one of claims 11-16 , wherein the plasma volume of the human measured at 30 minutes after administration of the oral composition is decreased by less than about 1%, or less than about 2%, or less than about 3%, or less than about 4%, or less than about 5%, or less than about 6%, or less than about 7%, or less than about 8%, or less than about 9%, or less than about 10% for at least about 30 minutes.

18 . The method of any one of claims 11-17 , wherein plasma osmolality of the human is maintained in a range from about 270 to about 330 mOsm/kg, or from about 280 to about 320 mOsm/kg, or from about 290 to about 310 mOsm/kg, or from about 290 to about 300 mOsm/kg, in at least 60 minutes after administration of the oral composition.

19 . A method for improving physical or sports performance, the method comprising administering any oral composition according to claims 1-10 .

20 . The oral composition of any one of claims 1-10 , wherein the oral composition comprises at least one essential amino acid and at least one non-essential amino acid.

21 . The method of any one of claims 11-19 , wherein the oral composition comprises at least one essential amino acid and at least one non-essential amino acid.

Assignees

• Coca Cola Co

Inventors

• Ren Haiyu
• Shi Yu
• Karava Nilesh Bansilal
• Gajula Dattatreya

Classifications

• A23L33/175

  Amino acids · CPC title

• A23L33/17

  Amino acids, peptides or proteins · CPC title

• A23L2/66

  Proteins · CPC title

• A23L2/52

  Adding ingredients (adding preservatives A23B70/10) · CPC title

• A23L2/39

  Dry compositions · CPC title